Levi Garraway, Roche CMO

Roche nabs an FDA OK for Gavre­to, trig­ger­ing a heavy­weight bout with ri­vals at Eli Lil­ly

Four months af­ter Eli Lil­ly’s Retev­mo got the first FDA OK to treat RET-al­tered tu­mors, Roche and Blue­print Med­i­cines are step­ping in­to the ring …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.